CN104415010A - Preparation method of antitumor micelle containing adriamycin - Google Patents
Preparation method of antitumor micelle containing adriamycin Download PDFInfo
- Publication number
- CN104415010A CN104415010A CN201310389647.3A CN201310389647A CN104415010A CN 104415010 A CN104415010 A CN 104415010A CN 201310389647 A CN201310389647 A CN 201310389647A CN 104415010 A CN104415010 A CN 104415010A
- Authority
- CN
- China
- Prior art keywords
- micelle
- antitumor
- acid
- drug
- polyacrylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a preparation method of an antitumor micelle containing adriamycin. The preparation method comprises the following steps: polymerizing acrylic acid by utilizing an atom transfer radical polymerization method, thus obtaining polyacrylic acid; modifying polyacrylic acid by utilizing folic acid molecules; polymerizing glutamic acid benzyl ester carboxylic acid anhydride by utilizing a ring opening polymerization method, thus obtaining polyglutamic acid benzyl ester; grafting adriamycin onto polyglutamic acid benzyl ester via hydrazone bonds; connecting polyacrylic acid with polyglutamic acid benzyl ester with bonds through click chemistry, thus obtaining block copolymers; after dissolving the block copolymers in tetrahydrofuran respectively, transferring the solutions into a dialysis bag, dialyzing the solutions with pure water, and filtering the dialysate with a filter membrane; freeze-drying the solutions after filtration, thus obtaining a drug loading micelle. The drug carrier micelle has a core/shell double-layer structure, wherein the outer layer is formed by hydrophilic polyacrylic acid, and the inner layer is a drug molecule coated layer. The material has the advantages that the material belongs to nanoparticles; the drug can achieve targeting delivery of cancer cells and pH-sensitive release in the cancer cells; the material has high drug loading capacity and good stability; the toxic and side effects of the drug on normal tissues and organs can be effectively reduced via the targeting function of the drug.
Description
Technical field
The present invention relates to a kind of preparation method of the antitumor micelle containing amycin, particularly relate to a kind of preparation method with the block macromolecular material pharmaceutical carrier micelle of cancer cell targeting.Belong to polymer chemistry and technical field of polymer.
Background technology
Cancer has become the main disease of harm humans health, and one of important means of Therapeutic cancer is Drug therapy, but many cancer therapy drugs also exist and are insoluble in the defect such as water, poor stability.As camptothecine, paclitaxel, amycin, 5-fluorouracil etc. are all difficult to because of poor solubility be utilized well by organism, solve the crux that its water solubility problems is this kind of pharmaceutical preparation clinical practice.In addition, oncotherapy and its effect of diagnostic medicine are nonselective mostly, and some normal structure organs often have more distribution, and under therapeutic dose, normal tissue organ toxic and side effects is large.Therefore solve how solubilising slightly solubility cancer therapy drug and increase medicine stability, improve the selectivity of cancerous cell extremely urgent.Therefore, finding a kind of reliable target medicine carrier is the key solving above two problems.
What macromolecule micelle pharmaceutical carrier generally adopted is all linear polymeric micelle.The research work that Bae seminar carries out is the most noticeable, and it points out in delivered research paper, is linked on main polymer chain by Dox key with hydrazone key, and utilizes pH in cancerous cell microenvironment to be that faintly acid makes hydrazone bond fission, achieves the target spot release of Dox.And, one section of paper (Bae Y, Jang W-D, Nishiyama N, Fukushima S, Kataoka K. that Bae delivered on Molecular BioSystems magazine in 2005
mol BioSyst2005; 1 (3): 242-250.), first simultaneously by Fol and Dox respectively key link PEG and PASP(poly-aspartate) on, thus having targeted delivery and the target spot release multifunctionality of medicine concurrently, Flow cytometry experiments (FCM) shows that cell is not significantly increased containing the polymer micelle of Fol the intake of polymer micelle.Gong Shaoqin seminar has also been engaged in similar research.It is with poly
caprolactone random copolymer is kernel, and PEG is shell, has prepared polymer nano micelle.Dox is connected with hydrazone key, and the PEG end group that utilized Fol to modify, prepare pH responsive type target drug-carrying micelle, test cellular uptake amount and cytotoxicity, prove that Dox discharges (Yang X, Grailer JJ, Pilla S fast due to the fracture of hydrazone key in acid condition, Steeber DA, Gong S.
bioconjugate Chem2010; 21 (3): 496-504.).
Although linear polymer micelle is as the carrier of poorly water soluble drugs, demonstrate huge advantage and potential passing in medicine process, but still there is micelle poor stability, solubilizing effect is not obvious, drug release rate is low problem.The drug loading of current polymer micelle can only reach about 5% usually, obtain higher drug loading very difficult.Research finds, polymer connects medicine monomer by chemical bond, can reach higher drug loading.And linear block copolymers load capacity is often on the low side, if but cross multikey to connect its micellar structure of drug molecule unstable again.And star-type polymer can overcome this deficiency.
Shanghai Communications University Yan De high mountain (Liu J, Pang Y, Huang W, Huang X, Meng L, Zhu X, Zhou Y, Yan D.
biomacromolecules2011; 12 (5): 1567-1577.) synthesize dendroid poly phosphate-polylactic-acid block copolymer and be applied to pharmaceutical carrier research, after parcel Dox, have obvious inhibitory action to HeLa cell.Another representative research is that Chinese University of Science and Technology Liu generation is brave, utilizes functionalization
the polymaleic anhydride star-type polymer modified with Fol and Dox prepared by cyclodextrin, and key has connected the gadolinium element to magnetic resonance effect sensitivity simultaneously, finds in mouse experiment, polymer micelle has obvious reinforcement (Liu T, Li X, Qian Y in the gathering at liver, kidney position, Hu X, Liu S.
biomaterials2012; 33 (8): 2521-2531.).
But because polymer architecture in star-type polymer is comparatively complicated, poor biocompatibility appears in prepared pharmaceutical carrier, drug encapsulation ability declines, the problems such as dendrimer surface drug macromolecule water-solubility reduction.In addition, dendrimer complex structure, synthesis cost is higher.These problems all limit the application of star-type polymer nano medicament carrying system.Therefore, no matter be property polymer or common star-type polymer pharmaceutical carrier, can not possess: target-oriented drug simultaneously, high drug carrying capacity, micellar structure is stablized, the pH sensitivity of target spot release, biocompatibility height these several plays the performance of most important effect to the clinical practice of polymer drug carrier system.
Summary of the invention
The object of the invention is the preparation method setting up a kind of antitumor micelle containing amycin, this pharmaceutical carrier micelle has the following advantages: belong to nanoparticle; Medicine can be realized to pH sensitivity release in cancerous cell targeted delivery and cancerous cell; Drug loading is large; Good stability; Its target function can effectively reduce medicine normal tissue organ toxic and side effects.
This micelle is a kind of star block copolymer with hydrophilic and hydrophobic block; Can by amycin key connect with block polymer on; Macromolecular material has two hydrophilic segments, a hydrophobic segment: its hydrophilic section of macromolecular material is polyacrylic acid, is modified by folic acid.Hydrophobic section is polyglutamic acid, by hydrazone keyed jointing branch amycin; High molecular micellar structure has nucleocapsid double-decker, and skin is hydrophilic polyacrylic, and internal layer is drug molecule integument.
Described block polymer is the polymer in following structural formula:
The technology of preparing scheme of block copolymer micelle is as follows:
1) nitrine micromolecule initiator is prepared
2) synthesis of folic acid-NHS molecule
3) polyacrylic atom transfer radical polymerization and modified with folic acid
4) synthesis of both arms alkynes end group poly benzyl glutamate
5) Dox molecule is connected with the hydrazone key of poly benzyl glutamate
6) synthesis of star block copolymer
7) nano-micelle is prepared
Polymer nano micelle is prepared by dialysis.Concrete grammar is: after one or both star polymers are dissolved in THF respectively, moves in bag filter, with 1000 mL pure water dialysis, refreshes the water periodically.After dialysis solution membrane filtration, lyophilization obtains copolymer carrier micelle.
By above technical scheme, tool of the present invention has the following advantages: the antitumor micelle volume 1) containing amycin is little, has nanoscale structures, can pass through various barrier in human body;
2) the antitumor micelle critical micelle concentration containing amycin is little, Stability Analysis of Structures;
3) the antitumor Micellar drug load capacity containing amycin is large, and good biocompatibility;
4) the antitumor micelle containing amycin has Targeting delivery pharmic function, can effectively reduce medicine normal tissue organ toxic and side effects.
Accompanying drawing explanation
Fig. 1 is that this contains the structural representation of the antitumor micelle of amycin;
Fig. 2 is that this contains the schematic diagram of the antitumor micelle of amycin;
Fig. 3 is that this contains the AFM scintigram of the antitumor micelle of amycin.
Detailed description of the invention
For making enforcement object of the present invention, technical scheme and advantage more clear, below in conjunction with the drawings and specific embodiments of the present invention, the present invention is described in detail:
As shown in Figure 1, be the chemical constitution schematic diagram of the antitumor micelle containing amycin.This macromolecule is AB
22. type block macromolecular, have two hydrophilic section, and 3. a hydrophobic section formed.Key on each segment has connected different molecular structures:
Folic acid micromolecule 1. key is connected in polyacrylic acid molecule segment and 2. goes up, and is 2. prepared by Transfer Radical Polymerization;
3. the five-membered ring utilizing 1,3-Dipolar Cycloaddition to obtain and polyglutamic acid carry out coupling;
Utilize hydrazone key by segment 3. with Doxorubicin molecules 4. key link up.
As shown in Figure 2, containing the antitumor micelle of amycin by this AB
2assorted arm star block macromolecular assembling is formed.Its structure is respectively by 1. folic acid micromolecule; 2. polyacrylic acid molecule; 3. polyglutamic acid; 4. the composition such as Doxorubicin molecules.Macromolecule is in aqueous by hydrophobic interaction, and can self assembly be spherical micellar structure, high molecular micellar structure has nucleocapsid double-decker:
Skin be hydrophilic polyacrylic 2.;
Internal layer be polyglutamic acid 3., be drug molecule integument, internal layer can make drug molecule be wrapped in ball interior, thus realizes drug carrier function.
Figure 3 shows that AB
2assorted arm star block copolymer is the AFM scanogram of globular micelle structure that formed of self assembly in aqueous.Prove that macromolecule forms globular micelle structure homogeneous, good dispersion, does not reunite in aqueous, is conducive to realizing the delivery to drug molecule and release function.
Provide embodiment below to be specifically described the present invention; but it is worthy of note that following examples are only used to further illustrate the present invention; can not be interpreted as limiting the scope of the invention, some nonessential improvement that the person skilled in the art in this field makes the present invention according to the invention described above content and adjustment still belong to protection scope of the present invention.
Embodiment 1:
1. nitrine micromolecule initiator is prepared
Step one: 2-chloroethoxyethanol 5mL is dissolved in 25mL butanone, adds 4.5g NaN in solution
3, 2.5gBu
4nI, 10mg bicyclohexane also-hexaoxacyclooctadecane-6-6, mixture is heated to boiling, stir 24 hours.Filtered by mixture, precipitation acetone carries out cleaning down.The mixed solution obtained is the crude product of product, after mixed solution is concentrated, 90
oc carries out distillation and obtains pure substance.The 2-nitrine ethoxy ethanol obtained
1h NMR (CDCl
3):
3.70 (t, 2 H, C
h 2oH), 3.65 (t,
2h, HOCH
2c
h 2o), 3.56 (t, 2H, N
3cH
2c
h 2o), 3.37 (t, 2H, C
h 2n
3), and 2.56 (s, 1H, OH).
Step 2: by a kind of for step obtained 2-nitrine ethoxy ethanol 2g, alpha-chloro acyl chlorides 5.09g is dissolved in 30mL dichloromethane, reaction system is transferred in ice territory, is slowly added in reaction vessel by 6.8g dicyclohexylcarbodiimide, and stir.0.4g dimethylamino naphthyridine is dissolved in dichloromethane and instilled in reaction vessel in 10 minutes.Whole reaction system is 0
oreact 1 hour under C condition, then at room temperature react 24 hours.The cyclohexyl urea be precipitated out in course of reaction is filtered, and washs with dichloromethane.Extract with sodium bicarbonate solution (5%), then carry out drying with anhydrous magnesium sulfate.After reduced vacuum drying, be separated with silica gel chromatographic column, finally obtain product 2-chloro nitrine Ethoxyethane.
1H NMR (CDCl
3):
4.30 (t, 2H, CH
2OCO), 3.73 (t, 2H, COOCH
2C
H 2O), 3.67 (t, 2H, N
3CH
2C
H 2O), 3.35 (t, 2H, C
H 2N
3), and 1.92 (s, 6H, (CH
3)
2C)。
2. the synthesis of folic acid-NHS molecule
By 1.0g folic acid and 0. 495g N, N-dicyclohexylcarbodiimide (DCC) and 0. 463g N-hydroxysuccinimide (NHS) are dissolved in 20mL DMSO, at N
2the lower room temperature reaction 24h of protection, cross and filter byproduct of reaction N, N-dicyclohexyl urine (DCU), utilizes silica gel chromatographic column to be separated, can obtain folic acid-NHS molecule.
3. polyacrylic atom transfer radical polymerization and modified with folic acid
By the 2-nitrine ethyoxyl bromo acid 12mg obtained in step 2, add methanol, bipyridyl and cuprous bromide with the 5.4g acrylic acid ratio be dissolved in simultaneously in 2:1:1 in 25mL DMSO.By bleeding-ventilate for three times-thaw cycles carries out tube sealing to polymerization pipe.Be polymerized after 24 hours, with methanol, polymer be precipitated out, filter, dry stand-by.Polyacrylic acid obtained by 2g is dissolved in 20mL dichloromethane, adds 2.8mL ethylenediamine, polyacrylic terminal groups is modified, obtain the polymer of end group band primary amine.The polyacrylic acid that 2g end group is modified is warming up to 50
oc reacts 6h.Reactant liquor is loaded bag filter (MWCO=3500) after having reacted, the 2 days free folic acid of removing afterwards of dialysing in deionized water, changes water every day 3 times.Dialysis solution ether sedimentation, vacuum drying obtains product.
4. the synthesis of both arms alkynes end group poly benzyl glutamate
Step one: 16.8g 3,5-methyl dihydroxy benzoate and 26.2g propargyl bromide are dissolved in 300mL acetone, add 15.1g sodium carbonate in the solution, 0.1g bicyclohexane also-hexaoxacyclooctadecane-6-6.Reaction solution is carried out be heated to backflow, react 24 hours.By sedimentation and filtration after reaction terminates, filtrate carries out concentrating under reduced pressure, in methanol, carry out recrystallization, obtains product 3,5-diacetylene p-methoxybenzoic acid methyl ester.
1H NMR in CDCl
3,
δ(ppm): 2.55 (2H,
CCH), 3.91(3H,
CH 3 O), 4.73 (4H,
CH 2 CCH), 6.82 (1H, aromatic), 7.29 (2H, aromatic)。
Step 2: 6.25g3,5-diacetylene p-methoxybenzoic acid methyl ester is dissolved in 30mL methanol, 73.9g ethylenediamine is dissolved in 120mL ethylenediamine, and 0
oslowly be added dropwise in reaction vessel under C condition, the process that drips needs 1 hours, and reaction 96 hours under room temperature again after being added dropwise to complete.Be less than 40
orevolve in the water-bath of C to steam and remove unnecessary solvent, utilizing the mixed solution of benzene/methanol (9/1 v/v) to carry out recrystallization to mixed solution, in vacuum drying oven, drying 24 hours, obtains product N-amine ethyl 3,5-diethyl alkynyloxy group aniline.
1H NMR in CDCl
3,
δ(ppm): 1.61 (2H,
CH
2 NH 2), 2.55 (2H,
CCH), 2.95 (2H,
CH 2NH
2), 3.49 (2H, CONH
CH 2), 4.73 (4H,
CH 2CCH), 6.68 (1H, CO
NH), 6.76 (1H, aromatic), 7.05 (2H, aromatic)。
Step 3: by the product N-amine ethyl 3 obtained in 0.16g step 2,5-diethyl alkynyloxy group aniline is as initiator, utilize ring-opening polymerisation mode polymer poly benzyl glutamate carboxylic acid anhydrides 5.19g, monomer and initiator are added in polymerization pipe, and add dry DMF 15mL, react 24 hours under room temperature.Polymer absolute ether precipitates, dry 24 hours of vacuum drying oven.Obtain product both arms alkynes end group poly benzyl glutamate.
5. Doxorubicin molecules is connected with the hydrazone key of poly benzyl glutamate
The both arms alkynes end group poly benzyl glutamate obtained in 5.8mL hydrazine and 2.43g above-mentioned steps is dissolved in the dry DMF of 25mL, reaction system is heated to 40
oc, reacts 1 hour.Thick product absolute ether is precipitated, and by sedimentation and filtration, dry 24 hours of vacuum drying oven, obtains amido both arms alkynes end group poly benzyl glutamate.This product 5g and 0.34g amycin monomer are dissolved in DMSO, reaction system is heated to 30
oc, react 48 hours, the reaction mixture absolute methanol obtained precipitates, and by sedimentation and filtration, dry 24 hours of vacuum drying oven.The poly benzyl glutamate of obtained Doxorubicin molecules grafting.
6. AB
2the synthesis of assorted arm star block copolymer
The polyacrylic acid modify 3.8g end group and the poly benzyl glutamate of 7.8g Doxorubicin molecules grafting are dissolved in 20mL dry DMF, and add 6.93mg PMDETA.Reaction system is carried out-ventilation-thaw cycles of bleeding for three times, add rapidly cuprous bromide 5.47mg.Reaction is 35
oreact 24 hours under C condition.React the mixed solution obtained and cross silicagel column to remove unnecessary mantoquita and other impurity.The concentrated later absolute methanol of solution precipitates, and finally obtains AB
2assorted arm star block copolymer.
7. the preparation of polymer nano micelle
Polymer nano micelle is prepared by dialysis.Concrete grammar is: after one or both star polymers are dissolved in THF respectively, moves in bag filter, with 1000 mL pure water dialysis, refreshes the water periodically.After dialysis solution membrane filtration, lyophilization obtains copolymer carrier micelle.
Finally it should be noted that, above embodiment is only in order to illustrate technical scheme of the present invention and unrestricted, although with reference to preferred embodiment to invention has been detailed description, those of ordinary skill in the art should understand, can a point technical scheme for invention be modified or be replaced on an equal basis, and not departing from the spirit and scope of technical solution of the present invention, it all should be encompassed in the middle of right of the present invention.
Claims (8)
1., containing an antitumor micelle for amycin, its architectural feature is: described macromolecular material is the AB by two hydrophilic polyacrylic acid segments and the coupling of a hydrophobic poly benzyl glutamate segment
2type copolymer.
2. the method preparing the antitumor micelle containing amycin according to claim 1 is carried out as follows:
1) for causing the synthesis of the nitrine micromolecule initiator of acrylic monomers;
2) utilize folic acid micromolecule to carry out NHS activation, prepare folic acid-NHS molecule;
3) utilize the nitrine micromolecule initiator prepared by step 1), cause acrylic acid micromolecule and carry out atom transfer radical polymerization, obtain polyacrylic acid, utilize folic acid-NHS molecular modification polyacrylic acid simultaneously;
4) synthesis of both arms alkynes end group poly benzyl glutamate;
5) utilize Doxorubicin molecules to carry out grafting to poly benzyl glutamate, this reaction utilizes hydrazone key to connect;
6) click chemistry Reactive Synthesis star block copolymer is utilized;
7) polymer nano micelle is prepared by dialysis.
3. a kind of antitumor micelle containing amycin according to claim 2, is characterized in that solvent that in said method, synthesized by step 1), nitrine micromolecule initiator uses is any one in acetone, butanone, dioxane, acetonitrile.
4. a kind of antitumor micelle containing amycin according to claim 2, is further characterized in that the polymerization single polymerization monomer that in said method, step 4) uses is benzyl glutamate carboxylic acid anhydrides.
5. a kind of antitumor micelle containing amycin according to claim 2, is further characterized in that the polymer coupling reaction that in said method, step 6) is carried out must adopt Huisgen 1,3-Dipolar Cycloaddition.
6. a kind of antitumor micelle containing amycin according to claim 2, is further characterized in that in said method and needs to adopt following micromolecule initiator:
1) 2-chloro nitrine Ethoxyethane
2) N-amine ethyl 3,5-diethyl alkynyloxy group aniline.
7. the antitumor micelle containing amycin according to claim 2, is further characterized in that: this macromolecular material is the star block copolymer formed by coupling by the polyacrylic acid segment of modified with folic acid and the polyglutamic acid of amycin grafting.
8. the antitumor micelle containing amycin according to claim 2, be further characterized in that: described macromolecule micelle has nucleocapsid double-decker, skin is hydrophilic polyacrylic, and internal layer is drug molecule integument.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310389647.3A CN104415010A (en) | 2013-08-30 | 2013-08-30 | Preparation method of antitumor micelle containing adriamycin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310389647.3A CN104415010A (en) | 2013-08-30 | 2013-08-30 | Preparation method of antitumor micelle containing adriamycin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104415010A true CN104415010A (en) | 2015-03-18 |
Family
ID=52965837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310389647.3A Pending CN104415010A (en) | 2013-08-30 | 2013-08-30 | Preparation method of antitumor micelle containing adriamycin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104415010A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103977418A (en) * | 2014-04-30 | 2014-08-13 | 成都市绿科华通科技有限公司 | Preparation method of doxorubicin-containing anti-tumor micelles |
| CN105126114A (en) * | 2015-09-10 | 2015-12-09 | 成都市龙华新科技有限公司 | Preparation method of polymer drug with amphipathic structure |
| CN105169405A (en) * | 2015-09-10 | 2015-12-23 | 成都市龙华新科技有限公司 | Preparation method of adriamycin polymer drug |
| CN105194684A (en) * | 2015-09-10 | 2015-12-30 | 成都市龙华新科技有限公司 | Novel polymer medicine for treating cancers |
| CN105194683A (en) * | 2015-09-10 | 2015-12-30 | 成都市龙华新科技有限公司 | Polyacrylamide-containing self-assembled drug carrier microcapsule system |
-
2013
- 2013-08-30 CN CN201310389647.3A patent/CN104415010A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| JEAN RUEHL ET AL.: "Nitroxide-mediated polymerization to form symmetrical ABA triblock copolymers from a bidirectional alkoxyamine initiator", 《POLYMER》 * |
| 汤继辉等: "聚氨基酸作为药物载体的研究进展", 《中国药科大学学报》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103977418A (en) * | 2014-04-30 | 2014-08-13 | 成都市绿科华通科技有限公司 | Preparation method of doxorubicin-containing anti-tumor micelles |
| CN105126114A (en) * | 2015-09-10 | 2015-12-09 | 成都市龙华新科技有限公司 | Preparation method of polymer drug with amphipathic structure |
| CN105169405A (en) * | 2015-09-10 | 2015-12-23 | 成都市龙华新科技有限公司 | Preparation method of adriamycin polymer drug |
| CN105194684A (en) * | 2015-09-10 | 2015-12-30 | 成都市龙华新科技有限公司 | Novel polymer medicine for treating cancers |
| CN105194683A (en) * | 2015-09-10 | 2015-12-30 | 成都市龙华新科技有限公司 | Polyacrylamide-containing self-assembled drug carrier microcapsule system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104415010A (en) | Preparation method of antitumor micelle containing adriamycin | |
| CN104415013A (en) | Novel antitumor polymer drug containing adriamycin | |
| CN104415012A (en) | Preparation method of medical polymer drug | |
| CN104415342A (en) | Self-assembled drug carrier microcapsule system containing polypyrrolidone | |
| CN104415339A (en) | Self-assembled targeted nanometer drug carrier micelles | |
| CN105169405A (en) | Preparation method of adriamycin polymer drug | |
| CN104415344A (en) | Polymer drug microcapsule containing polyacrylic acid | |
| CN104415343A (en) | Self-assembled drug carrier microcapsule system containing polyacrylic acid | |
| CN104415003A (en) | Polymer nano drug microcapsule containing polypyrrolidone | |
| CN104414999A (en) | Anti-tumor targeted nanometer drug-loaded microcapsule preparation method | |
| CN103977418A (en) | Preparation method of doxorubicin-containing anti-tumor micelles | |
| CN104001182A (en) | Novel antitumor doxorubicin-containing macromolecular drug | |
| CN103977417A (en) | Preparation method of amphiphilic drug-loaded nanoparticles | |
| CN104415011A (en) | Preparation method of cellular microenvironment pH-sensitive micelle | |
| CN104415004A (en) | Preparation method of biocompatible polymer antitumor drug | |
| CN104415341A (en) | Preparation method of tumor cell micro-environmentally responsive targeted drug micelle | |
| CN104415007A (en) | Preparation method of tumor cell micro-environmentally responsive nano-micelle | |
| CN104415005A (en) | Novel anti-cancer polymer drug | |
| CN104434794A (en) | Novel adriamycin tumor cell inhibiting micelle preparation method | |
| CN104337767A (en) | Method for preparing pH sensitive drug carrier micelle | |
| CN104415002A (en) | Preparation method for antineoplastic high-molecular microcapsule | |
| CN104414996A (en) | Nano self-assembly drug carrier microcapsule system | |
| CN104337794A (en) | Intelligent amphiphilic targeting drug carrier system | |
| CN103990139A (en) | Preparation method for medicinal high-molecule carrier | |
| CN103990140A (en) | Nanometer self-assembly drug carrier system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150318 |